The post Former Hyperliquid Employee Closes HYPE Short with Small Loss as Holdings Shrink by 70,000+ HYPE Tokens appeared on BitcoinEthereumNews.com. According The post Former Hyperliquid Employee Closes HYPE Short with Small Loss as Holdings Shrink by 70,000+ HYPE Tokens appeared on BitcoinEthereumNews.com. According

Former Hyperliquid Employee Closes HYPE Short with Small Loss as Holdings Shrink by 70,000+ HYPE Tokens

According to Coinbob’s Popular Address Monitor, in the last hour the Ethereum address 0x7ae—tied to a Hyperliquid former employee—has closed its HYPE short position with a modest realized loss. The entry price averaged around $24.17 and the position size was near $24,000. Since the start of the month, the address has steadily pared HYPE spot holdings, trimming exposure from roughly $5.85 million to $2.43 million and offloading more than 70,000 tokens. Current HYPE holdings stand near 98,200 tokens, with a monthly loss of about $1.53 million. A Hyperliquid public statement confirms the address is a former employee dismissed in Q1 2024 and no longer affiliated with Hyperliquid Labs; management notes the actions do not reflect the team’s standards or values.

Source: https://en.coinotag.com/breakingnews/former-hyperliquid-employee-closes-hype-short-with-small-loss-as-holdings-shrink-by-70000-hype-tokens

Market Opportunity
Hyperliquid Logo
Hyperliquid Price(HYPE)
$24.31
$24.31$24.31
-1.65%
USD
Hyperliquid (HYPE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.